(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.96%) $81.14
(-2.26%) $1.946
(-0.19%) $2 298.50
(0.17%) $26.70
(-0.50%) $943.50
(0.14%) $0.938
(0.26%) $11.12
(0.12%) $0.801
(0.00%) $93.45
Live Chart Being Loaded With Signals
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas...
Stats | |
---|---|
Dagens volum | 17 500.00 |
Gjennomsnittsvolum | 70 532.00 |
Markedsverdi | 19.47B |
EPS | ¥0 ( 2024-04-12 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-07-10 |
Last Dividend | ¥9.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.99 |
ATR14 | ¥0.599 (0.12%) |
Volum Korrelasjon
Astena Holdings Co., Ltd. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Astena Holdings Co., Ltd. Korrelasjon - Valuta/Råvare
Astena Holdings Co., Ltd. Økonomi
Annual | 2023 |
Omsetning: | ¥51.98B |
Bruttogevinst: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2023 |
Omsetning: | ¥51.98B |
Bruttogevinst: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2022 |
Omsetning: | ¥49.64B |
Bruttogevinst: | ¥15.44B (31.11 %) |
EPS: | ¥14.56 |
FY | 2021 |
Omsetning: | ¥72.32B |
Bruttogevinst: | ¥16.60B (22.96 %) |
EPS: | ¥46.86 |
Financial Reports:
No articles found.
Astena Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.75 | 2001-05-28 |
Last Dividend | ¥9.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | ¥149.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 9.60 | |
Div.Growth Potential Score | 3.35 | |
Div. Directional Score | 6.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8336.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7721.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6879.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6250.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
4970.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4182.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3361.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
2438.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
9380.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8060.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0306 | 1.500 | 9.39 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0245 | 1.200 | 9.18 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0583 | 1.500 | -0.463 | -0.695 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.262 | 0.800 | 8.69 | 6.95 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.162 | 1.500 | -0.210 | -0.315 | [0.2 - 2] |
debtRatioTTM | 0.236 | -1.500 | 6.06 | -9.09 | [0 - 0.6] |
interestCoverageTTM | 22.43 | 1.000 | 2.81 | 2.81 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.546 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.323 | 1.000 | 7.95 | 7.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.364 | -1.364 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.226 | 1.000 | 9.86 | 9.86 | [0.2 - 2] |
assetTurnoverTTM | 0.798 | 0.800 | 8.01 | 6.41 | [0.5 - 2] |
Total Score | 9.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.08 | 1.000 | 8.88 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0583 | 2.50 | -0.298 | -0.695 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.65 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.118 | 1.500 | -2.55 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0669 | 1.000 | -0.826 | 0 | [0.1 - 0.5] |
Total Score | 3.35 |
Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.